Pain management programmes via video conferencing: a rapid review

Walumbe, Jackie; Belton, Joletta; Denneny, Diarmuid

doi:10.1515/sjpain-2020-0112

Cited by 23 publications

(23 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…These include patient concerns about losses in supportive peer relationships and patient–therapist relationships, 10 lack of resources encompassing both IT equipment and exercise equipment, unfamiliarity with video-communication systems and the need for clinician training and infrastructure investment. 5 During the project, we were able to resolve many of these issues with input from all staff engaged in PMP delivery and the patients. An important factor in finding these solutions was the selection of an appropriate software programme with functionalities that could meet patient and clinician needs.…”

Section: Discussionmentioning

confidence: 99%

“…A recent rapid review of PMPs delivered via video-conferencing 5 identified three papers up until April 2020 and determined that video-conferencing for PMPs was feasible, but there was little guidance on how to develop and deliver these. In this article, we describe how this goal was achieved at our institution, using a quality improvement (QI) approach and service user involvement.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Rapid design and implementation of a virtual pain management programme due to COVID-19: a quality improvement initiative

Williams

Booth

Cohen

et al. 2021

British Journal of Pain

View full text Add to dashboard Cite

Background: The COVID-19 pandemic interrupted the delivery of face-to-face pain services including pain management programmes in the United Kingdom with considerable negative impact on patients with chronic musculoskeletal pain. We aimed to develop and implement a remotely delivered pain management programme (PMP) using video-conferencing technology that contains all the core components of a full programme: the ‘virtual PMP’ (vPMP). By reporting on the process of this development, we endeavour to help address the paucity of literature on the development of remote pain management programmes. Methods: The vPMP was developed by an inter-disciplinary group of professionals as a quality improvement (QI) project. The Model for Improvement Framework was employed with patient involvement at the design phase and at subsequent improvements. Improvement was measured qualitatively with frequent and repeated qualitative data collection leading to programme change. Quantitative patient demographic comparisons were made with a patient cohort who had been on a face-to-face PMP pathway. Results: Sixty-one patients on the PMP waiting list were contacted and 43 met the criteria for the programme. Fourteen patients participated in three vPMP cycles. Patient involvement and comprehensive stakeholder consultation were essential to a robust design for the first vPMP. Continued involvement of patient partners during the QI process led to rapid resolution of implementation problems. The most prominent issues that needed action were technical challenges including training needs, participant access to physical and technological resources, participant fatigue and concerns about adequate communication and peer support. Conclusion: This report demonstrates how a remotely delivered PMP, fully in line with national guidance, was rapidly developed and implemented in a hospital setting for patients with chronic musculoskeletal pain. We also discuss the relevance of our findings to the issues of cost, patient experience, patient preferences and inequities of access in delivering telerehabilitation for chronic pain.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Rapid design and implementation of a virtual pain management programme due to COVID-19: a quality improvement initiative

Williams

Booth

Cohen

et al. 2021

British Journal of Pain

View full text Add to dashboard Cite

show abstract

“…The experience accumulated in the management of patients with cancer pain during the pandemic suggests that many episodes of NP-BTcP are not reported during periodic consultations but are recorded by the patient in the monitoring system [29]. In other words, the impact on quality of life is always present, but both patients and clinicians tend to underestimate the effect [30,31].…”

Section: Discussionmentioning

confidence: 99%

Multidimensional Statistical Technique for Interpreting the Spontaneous Breakthrough Cancer Pain Phenomenon. A Secondary Analysis from the IOPS-MS Study

Cascella

Crispo

Esposito

et al. 2021

Cancers

View full text Add to dashboard Cite

Breakthrough cancer pain (BTcP) is a temporary exacerbation of pain that “breaks through” a phase of adequate pain control by an opioid-based therapy. The non-predictable BTcP (NP-BTcP) is a subtype of BTcP that occurs in the absence of any specific activity. Since NP-BTcP has an important clinical impact, this analysis is aimed at characterizing the NP-BTcP phenomenon through a multidimensional statistical technique. This is a secondary analysis based on the Italian Oncologic Pain multiSetting—Multicentric Survey (IOPS-MS). A correlation analysis was performed to characterize the NP-BTcP profile about its intensity, number of episodes per day, and type. The multiple correspondence analysis (MCA) determined the identification of four groups (phenotypes). A univariate analysis was performed to assess differences between the four phenotypes and selected covariates. The four phenotypes represent the hierarchical classification according to the status of NP-BTcP: from the best (phenotype 1) to the worst (phenotype 4). The univariate analysis found a significant association between the onset time >10 min in the phenotype 1 (37.3%)’ vs. the onset > 10 min in phenotype 4 (25.8%) (p < 0.001). Phenotype 1 was characterized by the gastrointestinal type of cancer (26.4%) with respect to phenotype 4, where the most frequent cancer affected the lung (28.8%) (p < 0.001). Phenotype 4 was mainly managed with rapid-onset opioids, while in phenotype 1, many patients were treated with oral, subcutaneous, or intravenous morphine (56.4% and 44.4%, respectively; p = 0.008). The ability to characterize NP-BTcP can offer enormous benefits for the management of this serious aspect of cancer pain. Although requiring validation, this strategy can provide many indications for identifying the diagnostic and therapeutic gaps in NP-BTcP management.

show abstract

“…Access in rural and remote areas may be limited. Pain services via videoconference may be possible but are untested 61…”

Section: What Are the Management Options For Non-specific Low Back Pain?mentioning

confidence: 99%

Low back pain in people aged 60 years and over

Traeger

Underwood

Ivers

et al. 2022

BMJ

View full text Add to dashboard Cite

Pain management programmes via video conferencing: a rapid review

Cited by 23 publications

References 23 publications

Rapid design and implementation of a virtual pain management programme due to COVID-19: a quality improvement initiative

Rapid design and implementation of a virtual pain management programme due to COVID-19: a quality improvement initiative

Multidimensional Statistical Technique for Interpreting the Spontaneous Breakthrough Cancer Pain Phenomenon. A Secondary Analysis from the IOPS-MS Study

Low back pain in people aged 60 years and over

Contact Info

Product

Resources

About